Breakthrough Therapeutics for CLL and Other B-Cell Malignancies: Focus on BTK Inhibitors From Development to Clinical Integration

Activity

Progress
1
Course Completed
Activity Information

Physicians: Maximum of 2.00 AMA PRA Category 1 Credits

Released: January 31, 2023

Expiration: January 30, 2024

Jeff DONOTUSESharman
Jeff DONOTUSESharman, MD
Ian W. Flinn
Ian W. Flinn, MD, PhD
Susan M. O'Brien
Susan M. O'Brien, MD